In the article by B.M. Piraccini et al. 1 , there is an error in the subsection entitled “Safety assessment” on page 291.
The incorrect sentence reads:
Withdrawal rates due to treatment‐related TEAEs were 2.8% and 2.2% in the topical finasteride and placebo groups, respectively, and 7.1% in the topical finasteride group.
The correct sentence should read:
Withdrawal rates due to treatment‐related TEAEs were 2.8% and 2.2% in the topical finasteride and placebo groups, respectively, and 7.1% in the oral finasteride group.
Reference
- 1. Piraccini BM, Blume‐Peytavi U, Scarci F, Jansat JM, Falqués M, Otero R, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36:286–94. 10.1111/jdv.17738 [DOI] [PMC free article] [PubMed] [Google Scholar]